Regular assessment of renal function, proteinuria, and serological markers is crucial for monitoring lupus nephritis progression and treatment response.
Long-term follow-up data offer valuable insights into the sustained efficacy and safety of lupus nephritis treatments.
Extended data collection helps refine treatment protocols, guide clinical decisions, and improve patient outcomes by identifying long-term effects.
SHOW MORE
Panelists discuss the differences in efficacy and safety profiles between belimumab and voclosporin for lupus nephritis (LN) and how payers are evaluating their value, including considerations of cost-effectiveness in LN management.
How do you monitor patients with lupus nephritis for disease progression and treatment response? (Dr. Larranaga)
Three-year follow-up results of voclosporin from the AURORA-2 study were published earlier this year. What is the value of long-term follow-up data such as these in lupus nephritis? (Dr. Wells)